Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by Lumberfeverlongon Nov 03, 2016 8:13pm
160 Views
Post# 25422770

RE:RE:RE:RE:Death march begins

RE:RE:RE:RE:Death march beginsWhoever they bought the drug from if they bought the drug and not the shares of the company that engaged in the behaviour being investigated then CXR is not potentially liable for those actions.
cg16 wrote: DK1958, I don't think Kapvay was a Covis drug.

Concordia Pharmaceuticals Inc. (a division of Concordia Healthcare Inc.) has acquired Kapvay (clonidine), Orapred ODT (prednisolone), and Orapred OS (prednisolone) from fellow specialty pharmaco Shionogi Inc. It has also licensed exclusive rights to Shionogi’s Ulesfia (benzyl alcohol) for head lice.


<< Previous
Bullboard Posts
Next >>